HaystackAnalytics

HaystackAnalytics, founded in 2018 and headquartered in India, is a dynamic player in the Health Care industry, focused on advancing genomics technology. The company’s latest innovation, infexnᵀᴹ, is a universal infectious disease test aimed at empowering healthcare professionals through precise and personalized clinical decisions.

Their technology platform is designed to integrate seamlessly with hospitals and diagnostic labs, allowing for scalable, affordable, and easy-to-implement solutions that do not require additional upskilling. Through partnerships, HaystackAnalytics ensures accurate and accessible genomic diagnostics across the nation.

HaystackAnalytics advanced genomic diagnostics support healthcare providers in delivering expedited and accurate patient care, transforming how clinicians and labs operate. With a focus on making genomics accessible, their products bridge the gap between technology and practical application in healthcare settings.

The company’s last funding was a Non Equity Assistance investment on 07 April 2021 from India DeepTech.